Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 10201-10250 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT07134881
Navigating Advanced Illness Goals And Treatment With Digital Engagement (NAVIGATE)
NARecruiting
200 participants
Started: Aug 27, 2025 · Completed: Jul 31, 2027
5 conditions2 sponsors1 location
NCT07120100
Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors
NARecruiting
19 participants
Started: Aug 27, 2025 · Completed: Sep 15, 2028
2 conditions1 sponsor1 location
NCT07160400
A Study of IBI3032 in Chinese Healthy Participants and Participants With Overweight or Obesity
PHASE1Recruiting
92 participants
Started: Aug 27, 2025 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT07141381
A Study to Evaluate the Effect of Food and a Proton Pump Inhibitor on the Pharmacokinetics of VRN110755
PHASE1Recruiting
24 participants
Started: Aug 27, 2025 · Completed: Jan 30, 2026
1 condition1 sponsor1 location
NCT07161180
"Evaluation of the Pharmacokinetics of PBK_M2301 in Healthy Adults"
PHASE1Recruiting
32 participants
Started: Aug 27, 2025 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT07200908
A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
PHASE3Recruiting
172 participants
Started: Aug 27, 2025 · Completed: Sep 30, 2029
1 condition1 sponsor4 locations
NCT07147348
A First-in-human, Dose Escalation and Indication Expansion Study of BNT3212 as Monotherapy or in Combination With BNT327 in Adults With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
375 participants
Started: Aug 27, 2025 · Completed: Mar 31, 2028
1 condition3 sponsors2 locations
NCT07145190
SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment
N/ARecruiting
90 participants
Started: Aug 27, 2025 · Completed: Feb 29, 2028
1 condition1 sponsor12 locations
NCT07039396
Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Diabetic Foot Ulcers
NARecruiting
10 participants
Started: Aug 26, 2025 · Completed: Jan 1, 2026
1 condition2 sponsors1 location
NCT07061522
Effects of Smoking Addiction on Lower Limb Speed and Coordination
N/ARecruiting
24 participants
Started: Aug 26, 2025 · Completed: Jul 20, 2026
1 condition1 sponsor1 location
NCT07073807
Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy
NARecruiting
30 participants
Started: Aug 26, 2025 · Completed: Oct 31, 2026
2 conditions1 sponsor5 locations
NCT07159724
Turkish Version of the Usefulness, Satisfaction, and Ease of Use Questionnaire (USE): Reliability and Validity
N/ANot yet recruiting
220 participants
Started: Aug 26, 2025 · Completed: Sep 30, 2025
4 conditions1 sponsor0 locations
NCT07159880
LETROZOLE EXTENDED VS TRADITIONAL THERAPY FOR OVULATION INDUCTION IN WOMEN WITH PCOS: A RANDOMIZED CONTROLLED TRIAL
NARecruiting
20 participants
Started: Aug 26, 2025 · Completed: Jul 30, 2026
3 conditions1 sponsor1 location
NCT07159282
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
PHASE4Recruiting
60 participants
Started: Aug 26, 2025 · Completed: Aug 31, 2027
7 conditions2 sponsors1 location
NCT06872840
Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility
NARecruiting
36 participants
Started: Aug 26, 2025 · Completed: May 26, 2027
5 conditions3 sponsors1 location
NCT07142642
A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Teprotumumab (AMG 632) Administered Intravenously in Healthy Chinese Participants
PHASE1Active, not recruiting
20 participants
Started: Aug 26, 2025 · Completed: Nov 22, 2025
1 condition1 sponsor1 location
NCT06986434
CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms
EARLY_PHASE1Not yet recruiting
20 participants
Started: Aug 26, 2025 · Completed: Aug 25, 2028
1 condition1 sponsor1 location
NCT07032467
Social Media Addiction and Compulsive Exercise Behaviors
N/ARecruiting
187 participants
Started: Aug 26, 2025 · Completed: Jun 20, 2026
1 condition1 sponsor1 location
NCT07063823
A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
PHASE1Recruiting
18 participants
Started: Aug 26, 2025 · Completed: Feb 7, 2026
2 conditions2 sponsors1 location
NCT07102641
Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies
PHASE4Recruiting
825 participants
Started: Aug 26, 2025 · Completed: Dec 31, 2027
6 conditions1 sponsor1 location
NCT06977724
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD)
PHASE1Recruiting
36 participants
Started: Aug 26, 2025 · Completed: Mar 31, 2029
2 conditions1 sponsor2 locations
NCT07110441
Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers
PHASE1Recruiting
52 participants
Started: Aug 26, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06925321
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
PHASE3Recruiting
219 participants
Started: Aug 26, 2025 · Completed: Feb 29, 2028
1 condition2 sponsors1 location
NCT07029412
Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)
PHASE2Recruiting
10 participants
Started: Aug 26, 2025 · Completed: Jan 26, 2026
1 condition1 sponsor4 locations
NCT07038798
Deep rTMS for Mild Neurocognitive Disorder in Older Adults
NARecruiting
30 participants
Started: Aug 26, 2025 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT07167758
A Study Evaluating TRIV-509 in Atopic Dermatitis
PHASE2Recruiting
90 participants
Started: Aug 26, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor15 locations
NCT07150845
Phase 2b Study of EVO756 in Adults With Atopic Dermatitis
PHASE2Recruiting
120 participants
Started: Aug 26, 2025 · Completed: Jul 31, 2026
1 condition1 sponsor12 locations
NCT07145229
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
PHASE2Recruiting
380 participants
Started: Aug 26, 2025 · Completed: Jun 30, 2026
4 conditions1 sponsor5 locations
NCT07125586
Real-Time Diagnosis of Eosinophilic Nasal Polyps Using High-Sensitivity Spectroscopy
NANot yet recruiting
353 participants
Started: Aug 26, 2025 · Completed: Jun 1, 2028
1 condition1 sponsor0 locations
NCT07120698
Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)
PHASE2Not yet recruiting
115 participants
Started: Aug 26, 2025 · Completed: Jul 26, 2029
4 conditions5 sponsors0 locations
NCT07115550
A Single-center, Single-arm, Phase II Clinical Study of Iparomlimab and Tuvonralimab Injection Combined With Regorafenib in the Treatment of Advanced Second-line or Above Hepatocellular Carcinoma
NANot yet recruiting
24 participants
Started: Aug 26, 2025 · Completed: Aug 26, 2028
1 condition1 sponsor0 locations
NCT07121023
To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hallux Valgus Orthopedic Surgery
PHASE1Not yet recruiting
32 participants
Started: Aug 26, 2025 · Completed: Dec 27, 2025
1 condition2 sponsors1 location
NCT07148011
Radicle Revive™ CSP: A Trial Evaluating Plant-Based Health and Wellness Products on Perimenopausal Women's Self-Reported Health Issues and Outcomes
NAActive, not recruiting
900 participants
Started: Aug 26, 2025 · Completed: Sep 26, 2026
1 condition1 sponsor1 location
NCT07203287
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
PHASE4Recruiting
490 participants
Started: Aug 26, 2025 · Completed: Aug 26, 2027
3 conditions1 sponsor1 location
NCT07122687
IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
PHASE2Recruiting
170 participants
Started: Aug 26, 2025 · Completed: Apr 30, 2030
1 condition1 sponsor1 location
NCT07042594
Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD1119 in Healthy Participants
PHASE1Recruiting
32 participants
Started: Aug 26, 2025 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06960382
Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma
PHASE1/PHASE2Not yet recruiting
36 participants
Started: Aug 26, 2025 · Completed: Mar 31, 2028
2 conditions1 sponsor1 location
NCT07073911
Effect of Exercise on Muscle Activity, Strength, and Balance in People With Knee Osteoarthritis
NANot yet recruiting
42 participants
Started: Aug 26, 2025 · Completed: Jun 19, 2026
1 condition2 sponsors1 location
NCT07053826
Penile Lengthening Pre-Penile Prosthesis Implantation
NARecruiting
48 participants
Started: Aug 26, 2025 · Completed: Feb 28, 2027
1 condition2 sponsors1 location
NCT07053059
Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)
PHASE2Recruiting
30 participants
Started: Aug 26, 2025 · Completed: May 31, 2030
1 condition2 sponsors1 location
NCT07157423
A Research Study to See How Safe is Eptacog Alfa When Used to Stop Heavy Bleeding in Women After Giving Birth in India
PHASE4Recruiting
64 participants
Started: Aug 26, 2025 · Completed: Mar 26, 2027
1 condition1 sponsor8 locations
NCT07156253
Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors
PHASE1Recruiting
110 participants
Started: Aug 26, 2025 · Completed: Feb 25, 2029
5 conditions1 sponsor2 locations
NCT07155564
Validation of Energy Expenditure Measures Study
N/ARecruiting
34 participants
Started: Aug 26, 2025 · Completed: Jan 31, 2029
2 conditions3 sponsors1 location
NCT07155824
Impact of Plant Proteins and Exercise on Protein Metabolism in Older Adults
NARecruiting
12 participants
Started: Aug 26, 2025 · Completed: Feb 28, 2027
2 conditions6 sponsors1 location
NCT07155252
Home-based Oral Glucose Tolerance Test for Type 1 Diabetes Screening
N/ARecruiting
60 participants
Started: Aug 26, 2025 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT07142850
A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Bolus and Infusion HRS-9190 in Healthy Adults
PHASE1Recruiting
40 participants
Started: Aug 26, 2025 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT07135375
Postoperative Rotator Cuff Rehabilitation: Functional, Pain and Sleep Quality
NARecruiting
50 participants
Started: Aug 26, 2025 · Completed: Mar 30, 2026
6 conditions1 sponsor2 locations
NCT07164833
A Study to Evaluate the Efficacy and Safety of BX-001N in Preventing Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) and Major Adverse Kidney Events (MAKE)
PHASE2Recruiting
40 participants
Started: Aug 26, 2025 · Completed: Feb 28, 2027
2 conditions1 sponsor5 locations
NCT07169734
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
PHASE1/PHASE2Recruiting
180 participants
Started: Aug 26, 2025 · Completed: Oct 4, 2029
5 conditions1 sponsor2 locations
NCT07201844
The Effect of Patient Preference for Treatment Model in Internet Delivered Cognitive Behavior Therapy for Generalized Anxiety Disorder
NARecruiting
440 participants
Started: Aug 26, 2025 · Completed: Aug 31, 2028
1 condition1 sponsor1 location